- Nielsen survey: Price most persuasive when incentivizing brand switch; improved features least influential
- P&G's new Crest Be aims to offer 'unexpected experience'
- ROUNDTABLE: Improving patient outcomes, controlling costs with OTCs
- Curtin, Mack talk strategic alignment and the art of co-creation at Shopper Marketing Expo
- Vitamins and Supplements 2014
PHILADELPHIA According to a study released by the Relational Capital Group, despite product recalls and a plant closure, consumer purchase intent and brand loyalty for Tylenol still currently exceeds that of Advil.
According to the study, conducted by Princeton University professors Susan Fiske and Nicolas Kervyn, 76% of consumers reported positive purchase intent and 67% reported positive brand loyalty for Tylenol, compared with 75% and 65% for Advil, respectively. In addition, Tylenol matched or surpassed Advil on most warmth and competence dimensions, including “acts with your best interests in mind.” Warmth and competence dimensions are both indicators of brand loyalty.
“This suggests that despite how painful the product recalls and plant closure have been for [McNeil Consumer], it appears their efforts thus far have been effective in retaining consumer trust and brand loyalty,” stated Chris Malone, chief advisory officer of The Relational Capital Group.
Conducted July 1 to 7, this study measured the warmth and competence perceptions and priorities of a demographically balanced sample of 1,042 U.S. adult consumers for eight national brands, as well as their purchase intent and brand loyalty toward each. The brands examined included McDonalds, Burger King, BP, Shell, Tropicana, Minute Maid, Tylenol and Advil.